- Reaction score
- 122
I like that they are thinking of starting trials in countries other than the US primarily japan or south korea, i also like this
"some cases it could be a complimentary drug which supports the development of our hair follicles and could actually have better efficacy than what’s on the market.
We make a lot of these cells so we have a unique platform to test drug candidates on these cells which no one else has. So, it’s something on our minds. There are all sorts of ways that we can manipulate these cells through drug molecules to either upregulate activity or downregulate, if you wanted to get rid of armpit hair, or back hair, for example. So, there is a list of opportunities in front of us, but we’re not actually working on those yet, we’re solely focused on the breakthrough of making new hair follicles. "
because this is really a solid opportunity they do indeed have.
they also commented on what I made a post on two days ago, the DHT sensitivity question of their newly produced cells. they said they have not looked into this at this point but i think its good that they have it in mind and are working with real samples of patients with AA, they definitely have this on the map and who knows, this research might advance the understanding of AA as a whole, i think it obviously will because to make a cell that is dht resistent you really have to understand what constitutes that and then actually make the cells enter this kind of epigenetic program which i dont understand how one would even accomplish that. like, can you force an expression pattern onto a cell manually? after all thats exactly what programming an IPC is all about, just with different genes, not those that are upregulated to give a cell pluripotency but those who make it resistant to dht... sounds EXTREMELY challenging
"some cases it could be a complimentary drug which supports the development of our hair follicles and could actually have better efficacy than what’s on the market.
We make a lot of these cells so we have a unique platform to test drug candidates on these cells which no one else has. So, it’s something on our minds. There are all sorts of ways that we can manipulate these cells through drug molecules to either upregulate activity or downregulate, if you wanted to get rid of armpit hair, or back hair, for example. So, there is a list of opportunities in front of us, but we’re not actually working on those yet, we’re solely focused on the breakthrough of making new hair follicles. "
because this is really a solid opportunity they do indeed have.
they also commented on what I made a post on two days ago, the DHT sensitivity question of their newly produced cells. they said they have not looked into this at this point but i think its good that they have it in mind and are working with real samples of patients with AA, they definitely have this on the map and who knows, this research might advance the understanding of AA as a whole, i think it obviously will because to make a cell that is dht resistent you really have to understand what constitutes that and then actually make the cells enter this kind of epigenetic program which i dont understand how one would even accomplish that. like, can you force an expression pattern onto a cell manually? after all thats exactly what programming an IPC is all about, just with different genes, not those that are upregulated to give a cell pluripotency but those who make it resistant to dht... sounds EXTREMELY challenging